Omnicell, Inc.
OMCL Healthcare Health Information Services
Omnicell, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 6.53% from fiscal 2024.
- Revenue
- −0.89%
- EPS
- +100.5%
- Free cash flow
- +42.6%
- Total debt
- +0.73%
Quarter to September 2026, against a year earlier
Follow OMCL
Alert me
Omnicell, Inc. (OMCL) P/E ratio
As of 5 November 2026, Omnicell, Inc. (OMCL) trades at a P/E ratio of 39.0×. Over the past ten years it has ranged from 0.0× (December 2024) to 1,285× (January 2026); the current reading is higher than 25% of that period. That is below the Health Information Services industry median of 42.0× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 1,133× | 586.83% |
| FY2024 | 165× | — |
| FY2023 | 0.0× | — |
| FY2022 | 368× | 265.20% |
| FY2021 | 101× | (35.33%) |
| FY2020 | 156× | 182.29% |
| FY2019 | 55.2× | (13.44%) |
| FY2018 | 63.8× | (26.48%) |
| FY2017 | 86.8× | (32.40%) |
| FY2016 | 128× | 255.17% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 35.1× | (28.18%) |
| Jun 2026 | 48.8× | (35.61%) |
| Mar 2026 | 75.9× | (93.30%) |
| Dec 2025 | 1,133× | 1,499.26% |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CERT Certara, Inc. compare | n/m |
| SDGR Schrodinger, Inc. compare | n/m |
| TDOC Teladoc Health, Inc. compare | n/m |
| OMCL Omnicell, Inc. | 39.0× |
| HSTM HealthStream, Inc. compare | 42.0× |
| GDRX GoodRx Holdings, Inc. compare | 65.7× |
| PHR Phreesia, Inc. compare | 74.4× |
| PRVA Privia Health Group, Inc. compare | 88.3× |
| OMDA Omada Health, Inc. compare | 267× |
| Health Information Services industry median | 42.0× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)